n-methyl-3,4-methylenedioxyamphetamine and n-oleoylethanolamine

n-methyl-3,4-methylenedioxyamphetamine has been researched along with n-oleoylethanolamine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bermudez-Silva, FJ; Berrendero, F; De Fonseca, FR; Fernandez-Espejo, E; Maldonado, R; Parsons, LH; Pavon, FJ; Plaza-Zabala, A; Robledo, P; Serrano, A; Suarez, J1

Other Studies

1 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and n-oleoylethanolamine

ArticleYear
Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice.
    Synapse (New York, N.Y.), 2010, Volume: 64, Issue:5

    Topics: Animals; Avoidance Learning; Cognition Disorders; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Endocannabinoids; Hallucinogens; Male; Mental Recall; Mesencephalon; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Nootropic Agents; Oleic Acids; PPAR alpha; Rats; Rats, Wistar; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase

2010